If you take tirzepatide and use the pill, there's one thing you need to know up front: tirzepatide can make oral birth control less reliable, and the FDA label says to use a backup barrier method, or switch to a non-oral method, for 4 weeks after you start and for 4 weeks after every dose increase. Semaglutide does not carry this warning. That single difference is why "which GLP-1 am I on?" is a real contraception question, not a technicality.
Key takeaways
- Tirzepatide (the medicine in Mounjaro and Zepbound) can reduce the effectiveness of oral hormonal contraceptives, the combined pill and the progestogen-only "mini-pill."
- The FDA label advises a backup barrier method or a non-oral contraceptive for 4 weeks after starting and 4 weeks after each dose increase.
- Semaglutide does not carry this warning. A pharmacokinetic study found it did not reduce the levels of a combined oral contraceptive.
- Non-oral methods aren't affected: the hormonal or copper IUD, the implant, the injection, the vaginal ring, and the patch.
- Fertility can return with weight loss, and GLP-1s are not safe in pregnancy, so reliable contraception matters. Talk to a licensed provider about your plan.
Does tirzepatide make birth control less effective?
Yes, but only oral birth control. The FDA prescribing information for both tirzepatide products, Mounjaro and Zepbound, states that using tirzepatide may reduce the efficacy of oral hormonal contraceptives because the drug delays gastric emptying (how quickly your stomach empties). When your stomach empties more slowly, a swallowed pill can be absorbed less completely, so less of the hormone reaches your bloodstream. The effect is largest after your first dose and after each dose increase, then eases over time.
A quick note on the names so the label language makes sense. Tirzepatide is the active ingredient in Mounjaro, which is FDA-approved for type 2 diabetes (using it for weight loss is off-label), and Zepbound, which is FDA-approved for chronic weight management. Both labels carry the same birth-control instruction because it comes from how tirzepatide behaves in the body, not from any one brand.
Why does tirzepatide affect the pill but semaglutide doesn't?
Both drugs slow gastric emptying, but only tirzepatide's effect was significant enough to change the guidance for oral contraceptives. For semaglutide, the maker's own drug-interaction research told a different story.
In a study published in The Journal of Clinical Pharmacology in 2015, researchers gave women a combined oral contraceptive (ethinylestradiol plus levonorgestrel) with and without semaglutide. Semaglutide did not reduce the contraceptive's bioavailability, estrogen levels stayed within the equivalence range, and progestin levels were actually slightly higher, not lower. The FDA label for Wegovy reflects this: it notes that in clinical pharmacology trials, semaglutide "did not affect the absorption of orally administered medications," and it does not tell patients to add a backup method. (Semaglutide is the active ingredient in Wegovy, FDA-approved for chronic weight management, and Ozempic, FDA-approved for type 2 diabetes, using it for weight loss is off-label.)
So the practical contrast looks like this:
| Tirzepatide (Mounjaro, Zepbound) | Semaglutide (Wegovy, Ozempic) | |
|---|---|---|
| FDA label instruction on oral birth control | Yes, switch to a non-oral method or add a barrier method for 4 weeks after starting and after each dose increase | No such instruction |
| Why | Slows gastric emptying enough to lower pill absorption early on | Pharmacokinetic study found no meaningful drop in contraceptive levels |
| Non-oral methods affected? | No | No |
One caveat worth naming: this semaglutide research is for the injectable form (the kind Elara compounds). It's the injectable semaglutide label that carries no oral-contraceptive instruction.
How long do you need backup birth control on tirzepatide?
Four weeks, twice. According to the FDA labels for Mounjaro and Zepbound, if you're on an oral contraceptive you should either switch to a non-oral method or add a barrier method (like condoms):
- For 4 weeks after your first tirzepatide dose, and
- For 4 weeks after every dose increase during titration.
Tirzepatide is usually stepped up over several months (2.5 mg to 5 mg, then higher), so in practice you may have several of these 4-week windows in your first half-year. A simple way to stay covered is to use condoms during each window, or move to a non-oral method you don't have to think about dose-by-dose. Your provider can help you map the windows to your specific dose schedule. This interaction is a property of tirzepatide itself, so the same precaution applies whether the tirzepatide is branded or compounded, bring it up with your prescriber.
Which birth control methods aren't affected by tirzepatide?
Anything that isn't swallowed. The FDA label is explicit that hormonal contraceptives not taken by mouth should not be affected, because the slowed-stomach issue only applies to pills you have to absorb through your digestive tract.
| Birth control method | Route | Affected by tirzepatide? | What to do |
|---|---|---|---|
| Combined pill (estrogen + progestin) | Oral | Yes, may be less reliable early on | Add a barrier method or switch to a non-oral method for the 4-week windows |
| Progestogen-only "mini-pill" | Oral | Yes | Same as above |
| Hormonal IUD (e.g., Mirena, Kyleena) | Non-oral | No | No change needed |
| Copper IUD (Paragard) | Non-oral | No | No change needed |
| Contraceptive implant (Nexplanon) | Non-oral | No | No change needed |
| Contraceptive injection (Depo-Provera) | Non-oral | No | No change needed |
| Vaginal ring (e.g., NuvaRing) | Non-oral | No | No change needed |
| Transdermal patch (e.g., Xulane) | Non-oral | No | No change needed |
If you're starting tirzepatide and want to stop worrying about backup windows entirely, a long-acting non-oral method (IUD, implant, or injection) is worth discussing with your provider before your first dose.
Can you get pregnant on tirzepatide, and why does this matter so much?
Yes, you can, and that's exactly why the birth-control point is a big deal. GLP-1 medications are not fertility drugs, but losing weight and improving insulin sensitivity can restore ovulation in women who weren't ovulating regularly, especially with PCOS, one reason a GLP-1 can shift or restart your cycle. Combine returning fertility with a pill that's temporarily less reliable, and an unplanned pregnancy becomes more possible than many women expect.
That matters because GLP-1 medications, including tirzepatide, are not recommended during pregnancy. Current guidance is to stop well before trying to conceive, for semaglutide, about two months (roughly 8 weeks) ahead. We cover the timing in detail in when to stop before trying to conceive and the bigger picture in GLP-1s, fertility, and "Ozempic babies". The short version: if pregnancy is on your radar at all, make contraception and timing a planned conversation with your clinician, not an afterthought.
A quick note on tirzepatide safety
Birth control isn't the only thing to review before starting. Tirzepatide carries a boxed warning for thyroid C-cell tumors and is contraindicated if you or a close family member has had medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), per the FDA labels. Other cautions include pancreatitis, gallbladder problems, and significant gastrointestinal side effects such as nausea, and low blood sugar if you also take insulin or a sulfonylurea. This isn't the full list, read the FDA prescribing information and talk to a licensed provider about your history before starting.
How Elara helps
Elara is a women's telehealth program, so questions like "does my GLP-1 change how my birth control works?" are exactly what a provider reviews with you, not an afterthought. If tirzepatide is appropriate for you, a licensed provider walks through your contraception, your pregnancy plans, and your dose schedule, and helps you plan the backup windows the label calls for. If semaglutide fits you better, that's part of the conversation too.
About compounded medications: Compounded semaglutide and tirzepatide are prepared by a
state-licensed compounding pharmacy and prescribed by a licensed clinician when appropriate for you.
**Compounded medications are not FDA-approved and are not reviewed by the FDA for safety,
effectiveness, or quality.** They are not "generic" versions of Ozempic®, Wegovy®, Mounjaro®, or
Zepbound®. Talk to a licensed clinician about whether a compounded or FDA-approved option is right for you.
Considering tirzepatide? Elara's compounded tirzepatide program starts at $355/month (about $298/month on the 12-month plan), all-inclusive: provider visit, medication, shipping, ongoing support, and the Elara app. Cash-pay, all 50 states and Puerto Rico. A licensed provider reviews every patient. Prefer to compare? See Elara's compounded semaglutide program or start with the weight-loss program overview.
Frequently asked questions
Does tirzepatide make birth control less effective?
It can make oral birth control less effective. The FDA labels for Mounjaro and Zepbound (both tirzepatide) say the drug may reduce the efficacy of oral hormonal contraceptives because it slows gastric emptying and lowers pill absorption. Non-oral methods are not affected. Use a backup method during the windows your provider identifies.
How long do I need backup birth control on tirzepatide?
Use a barrier method, or switch to a non-oral contraceptive, for 4 weeks after your first dose and 4 weeks after each dose increase, according to the FDA labels. Because tirzepatide is titrated up over months, you may have several of these windows early on. Your provider can map them to your dose schedule.
Does semaglutide affect birth control pills?
Semaglutide does not carry the oral-contraceptive warning that tirzepatide does. In a 2015 pharmacokinetic study, injectable semaglutide did not reduce the levels of a combined oral contraceptive, and the Wegovy label notes semaglutide did not affect the absorption of oral medications. If severe vomiting or diarrhea occurs, treat it like a missed pill.
Which birth control methods aren't affected by tirzepatide?
Any method that isn't swallowed: the hormonal IUD, copper IUD, contraceptive implant, injection (Depo-Provera), vaginal ring, and patch. The FDA label states that hormonal contraceptives not taken by mouth should not be affected, because tirzepatide's interaction is about slowed absorption of oral pills, not the hormones themselves.
Can you get pregnant on tirzepatide?
Yes. Tirzepatide is not a fertility drug, but weight loss and improved insulin sensitivity can restore ovulation, while oral birth control is temporarily less reliable. Because GLP-1 medications are not recommended in pregnancy, use dependable contraception and plan any pregnancy with your clinician, stopping the medication well in advance.
The bottom line
Tirzepatide can lower the effectiveness of the pill, so the FDA advises a backup barrier method or a non-oral option for 4 weeks after starting and after each dose increase, while semaglutide carries no such warning. If you use oral birth control, the safest move is a quick plan with your provider before your first dose. Reliable contraception matters here because fertility can return, and GLP-1s aren't safe in pregnancy.
References
- U.S. Food and Drug Administration / Eli Lilly. "MOUNJARO (tirzepatide) injection, Prescribing Information" (Boxed Warning; Drug Interactions: oral hormonal contraceptives). DailyMed, 2025. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d2d7da5d-ad07-4228-955f-cf7e355c8cc0
- U.S. Food and Drug Administration / Eli Lilly. "ZEPBOUND (tirzepatide) injection, Prescribing Information" (Boxed Warning; Drug Interactions: oral hormonal contraceptives; chronic weight management indication). DailyMed, 2025. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b
- U.S. Food and Drug Administration / Novo Nordisk. "WEGOVY (semaglutide) injection, Prescribing Information" (Boxed Warning; Drug Interactions; chronic weight management indication). DailyMed, 2025. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f5e548d0-cc79-4c34-a3f5-e20a5b8b6564
- Kapitza C, et al. "Semaglutide, a Once-Weekly Human GLP-1 Analog, Does Not Reduce the Bioavailability of the Combined Oral Contraceptive, Ethinylestradiol/Levonorgestrel." The Journal of Clinical Pharmacology, 2015. https://pmc.ncbi.nlm.nih.gov/articles/PMC4418331/
This article is for general education and is not medical advice. It doesn't replace a conversation
with a licensed clinician about your health, medications, or treatment. Reading it doesn't create a
doctor-patient relationship. If you have a medical emergency, call 911. See our full
Medical Disclaimer.